Crispr Therapeutics shares owned by Versant Venture Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Versant Venture Management
from 13F filings
Historical chart of Versant Venture Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Versant Venture Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $23M | 499k | 46.98 |
| 2024-06-30 | $27M | 499k | 54.01 |
| 2024-03-31 | $34M | 499k | 68.16 |
| 2023-12-31 | $31M | 499k | 62.60 |
| 2023-09-30 | $23M | 499k | 45.39 |
| 2023-06-30 | $28M | 499k | 56.14 |
| 2023-03-31 | $23M | 499k | 45.23 |
| 2022-12-31 | $20M | 499k | 40.65 |
| 2022-09-30 | $33M | 499k | 65.35 |
| 2022-06-30 | $30M | 499k | 60.77 |
| 2022-03-31 | $31M | 499k | 62.77 |
| 2021-12-31 | $38M | 499k | 75.78 |
| 2021-09-30 | $56M | 499k | 111.93 |
| 2021-06-30 | $82M | 509k | 161.89 |
| 2021-03-31 | $190M | 1.6M | 121.85 |
| 2020-12-31 | $466M | 3.0M | 153.11 |
| 2020-09-30 | $304M | 3.6M | 83.64 |
| 2020-06-30 | $307M | 4.2M | 73.49 |
| 2020-03-31 | $177M | 4.2M | 42.14 |
| 2019-12-31 | $256M | 4.2M | 60.91 |
| 2019-09-30 | $174M | 4.2M | 40.99 |
| 2019-06-30 | $200M | 4.2M | 47.10 |
| 2019-03-31 | $152M | 4.2M | 35.72 |
| 2018-12-31 | $103M | 3.6M | 28.57 |
| 2018-09-30 | $160M | 3.6M | 44.35 |
| 2018-06-30 | $212M | 3.6M | 58.76 |
| 2018-03-31 | $211M | 4.6M | 45.71 |
More positions owned by Versant Venture Management
View all positions for Versant Venture Management